The risky business of dopamine agonists in Parkinson disease and impulse control disorders.
about
Dopamine Replacement Therapy, Learning and Reward Prediction in Parkinson's Disease: Implications for RehabilitationInvestigating the mechanism(s) underlying switching between states in bipolar disorderComputational model of precision grip in Parkinson's disease: a utility based approachProficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors.The Influence of Bilateral Subthalamic Nucleus Deep Brain Stimulation on Impulsivity and Prepulse Inhibition in Parkinson's Disease Patients.Dopamine agonists and the suppression of impulsive motor actions in Parkinson disease.From prediction error to incentive salience: mesolimbic computation of reward motivation.Trends and issues in characterizing early cognitive changes in Parkinson's disease.Impulse control and related disorders in Parkinson's disease.Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control studyLinking neuroscience with modern concepts of impulse control disorders in Parkinson's disease.A conditioned response as a measure of impulsive-compulsive behaviours in Parkinson's disease.A tribute to charlie chaplin: induced positive affect improves reward-based decision-learning in Parkinson's diseaseIndividual differences in risky decision-making among seniors reflect increased reward sensitivity.Impulse control disorders in Parkinson's disease: background and update on prevention and management.Impulsivity and apathy in Parkinson's disease.Pramipexole Increases Go Timeouts but Not No-go Errors in Healthy Volunteers.Factors associated with the development of impulse compulsive disorders in Parkinson patients.Psychiatric issues in cognitive impairment.Dopamine Agonists and Impulse Control Disorders: A Complex Association.Dopaminergic and clinical correlates of pathological gambling in Parkinson's disease: a case report.Dopamine antagonism decreases willingness to expend physical, but not cognitive, effort: a comparison of two rodent cost/benefit decision-making tasks.Animal models for bipolar disorder: from bedside to the cage.Part 2: Introduction to the Pharmacotherapy of Parkinson's Disease, With a Focus on the Use of Dopaminergic Agents.Pro-dopamine regulator, KB220Z, attenuates hoarding and shopping behavior in a female, diagnosed with SUD and ADHD.Risky decision-making and affective features of impulse control disorders in Parkinson's disease.The neurobiology of impulse control disorders in Parkinson's disease: from neurotransmitters to neural networks.Mesocorticolimbic hemodynamic response in Parkinson's disease patients with compulsive behaviors.Perceptual decision-making in patients with Parkinson's disease.Cognitive-Behavioral Therapy for Pathological Gambling in Parkinson s Disease: A Pilot Controlled StudyImpulsive and compulsive behaviors in Parkinson's diseaseImpulse Control Disorder in Parkinson's Disease: A Meta-Analysis of Cognitive, Affective, and Motivational CorrelatesIntermittent subthalamic nucleus deep brain stimulation induces risk-aversive behavior in human subjectsManagement of common adverse effects of antipsychotic medications
P2860
Q26744652-6A4BCE5F-AEA9-4D9C-9DFD-67A9A6BC7B6AQ28084519-9D4293C1-76E6-4EAA-BA9D-018338BA2841Q28661391-4519C008-15DE-4A9C-8720-D3C08ACD95B7Q30301190-683955C9-FFED-4FB7-A64C-A9CF8FFCE2ADQ30381782-FD97C29A-F517-4BB3-B9B3-0D3C527CA13CQ30419267-F6245223-B57E-495E-B36A-A41BDEBB30F1Q34266807-58609B4C-B3D9-444D-A790-79EDBF43E42EQ34403392-7694335E-3CD0-44FE-9804-5044F63F2788Q34434412-E2BED5DB-63ED-4CD7-B807-FC7A40AB0B5AQ34538553-48AFC23D-4FAB-4F27-BDA8-BB9D0880840FQ35054558-5A501A50-05FE-4609-A4F8-2DA344FE4096Q35107051-660E7308-A159-4307-9103-CB2F19C39CD9Q36029317-0D4CC742-F449-4748-8853-299B6E3079DBQ36099135-53E87CB1-5F49-46F0-B53B-5071CA741B56Q36768304-5C535BB0-0D49-48F1-949B-DF441AB1727EQ37331607-305FC60A-A085-4DAE-A010-2ED2CEF1BA59Q37345319-6C37BAF3-B714-4DF7-BE3C-BA266285CF76Q38075611-E22816DD-AAD4-4B45-A56E-2762147341B8Q38206498-4FA1702D-B535-4939-852B-754D03840560Q38598331-9FDFFBCD-1BAD-44B2-BCD7-C6C7750257DBQ41863549-6D4CF4B4-A711-47A2-BD81-315184CBCE2DQ42556171-121D5AD1-9CF0-42F6-AA40-A0558A0253BFQ42702891-3D845B28-BEFE-47D5-BED6-243AB26ACCFAQ43248920-378293EF-416C-477C-A709-87BCAD277A5EQ47297120-665B3297-817E-4036-9F6A-BBCC21A559DFQ47714523-866FCA77-5AE4-4B83-9964-B7951B7C40C4Q47830362-BD764D94-A2F5-4271-8EDC-844C3A08E677Q48631955-09A6F2C2-A2CB-4E15-8414-37AF4EB29B0DQ50222006-2C404BC9-8DE4-42DD-A2F0-804068BED7FCQ58039407-3CA578CE-5909-413F-A7E5-9D5964B102D5Q58492844-AC81FEFD-766F-4F24-82EF-107D3175556FQ58697810-6868210E-807D-481C-8D79-5A3EC3BCD171Q58756494-096DC710-7508-4AF4-9075-A89F71B33150Q58760350-92D744BD-451D-4937-B3BE-CC93D658AEB6
P2860
The risky business of dopamine agonists in Parkinson disease and impulse control disorders.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The risky business of dopamine ...... and impulse control disorders.
@en
type
label
The risky business of dopamine ...... and impulse control disorders.
@en
prefLabel
The risky business of dopamine ...... and impulse control disorders.
@en
P2093
P2860
P356
P1476
The risky business of dopamine ...... and impulse control disorders.
@en
P2093
Charles K Jessup
Daniel O Claassen
G Frederick Wooten
K Richard Ridderinkhof
Madaline B Harrison
Scott A Wylie
Wery P M van den Wildenberg
P2860
P304
P356
10.1037/A0023795
P577
2011-08-01T00:00:00Z